circRNA basic information
circBase ID: hsa_circ_0006906
Name: hsa_circ_SCP2
Synonym: circSCP2
Host Gene: SCP2
Genomic location(hg19): chr1:53459074-53459374:-
Genomic location(hg38): chr1:52993402-52993702:-
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005575
MONDO name: colorectal cancer
Disease details: colorectal cancer / CRC
Disease DO ID:
5672, 9256
Disease MeSH ID:
-
Disease NCIt ID:
C4978
Disease ICD11 ID:
-
Disease OMIM ID:
114500
Species: Human
Species details: Homo sapiens
Tissue specimen:

CRC tissues; paired normal tissues; serum exosomes / plasma exosomes; lung tissues; liver tissues

Cell lines:

SW480; SW620; DLD1; HCT116; RKO; HT29; LOVO; NCM460; HEK-293T; LX2; THP1

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: IGF2BP1, PTBP1
Associated microRNA: miR-92a-1-5p
Biological function: Promotes CRC cell proliferation, migration, invasion and metastasis; promotes EMT; modulates tumor-stroma microenvironment (CAF activation, M2 macrophage polarization); reduces sensitivity to oxaliplatin.
Molecular mechanism: Acts as a ceRNA sponging miR-92a-1-5p to upregulate IGF2BP1; directly binds PTBP1 and inhibits ubiquitination/proteasome-dependent degradation of PTBP1, enhancing PTBP1-mediated IGF2BP1 mRNA stabilization.
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); ceRNA regulation (promotes); immune regulation (promotes); drug resistance (promotes); ubiquitination (inhibits)

Detected method:
Q
M
Validation methods:

Microarray; RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; Sanger Sequencing; Back-Splice Junction PCR / divergent primers PCR; FISH / smFISH; Clinical Sample Validation; Bioinformatics Analysis; RNA-seq; Luciferase Reporter Assay; RNA Pull-Down; RIP (RNA Immunoprecipitation); Transfection; Western Blot; CCK8; EdU Staining; Transwell Assay; Wound Healing Assay; Colony Formation Assay; IF (Immunofluorescence); Co-IP; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry)

Clinical significance:

Higher levels in serum exosomes correlate with advanced TNM stages; high circSCP2 expression is associated with poor prognosis; exosomal circSCP2 is a promising circulating biomarker for CRC prognosis.

Description:

circSCP2 (hsa_circ_0006906) is up-regulated in CRC tissues and circulating/serum exosomes and promotes proliferation, EMT, invasion and metastasis. It acts as a miR-92a-1-5p sponge to increase IGF2BP1 and also binds PTBP1 to inhibit PTBP1 ubiquitination, thereby stabilizing PTBP1 and enhancing IGF2BP1 mRNA stability. Exosomal circSCP2 additionally influences the tumor microenvironment (e.g., CAF activation and M2 macrophage polarization) and is proposed as a prognostic circulating biomarker.

Confidence score:

0.8861

Other information
Title:

Exosomes containing circSCP2 in colorectal cancer promote metastasis via sponging miR-92a-1-5p and interacting with PTBP1 to stabilize IGF2BP1.

Journal: Biology direct
Published: 2024
PubMed ID: 39702234
Study type:

combined biological and clinical study

Data availability: 10.1186/s13062-024-00571-1
Code availability: -